AVITA Medical, Inc.
Ticker: 1762303
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 21.70+12.7% | 19.25+12.8% | 17.06-7.4% | 18.42-0.5% | 18.51-5.3% | 19.55+28.6% | 15.20+36.9% | 11.10 |
| Total Income | 21.70+12.7% | 19.25+12.8% | 17.06-7.4% | 18.42-0.5% | 18.51-5.3% | 19.55+28.6% | 15.20+36.9% | 11.10 |
| EXPENSES | ||||||||
| Expenditure | 28.56+1.8% | 28.05+7.0% | 26.22-11.3% | 29.57-2.5% | 30.34-9.0% | 33.35+8.2% | 30.82+8.9% | 28.31 |
| Tax | 0.03+400.0% | -0.01-150.0% | 0.02 | 0.00-100.0% | 0.01+133.3% | -0.03-200.0% | 0.03+0.0% | 0.03 |
| PROFIT | ||||||||
| PBT | -7.63+28.2% | -10.62+19.4% | -13.17-32.8% | -9.92+28.4% | -13.85+14.7% | -16.23-5.7% | -15.36+17.6% | -18.63 |
| Net Profit | -7.66+27.8% | -10.61+19.6% | -13.19-33.0% | -9.92+28.4% | -13.86+14.5% | -16.21-5.3% | -15.39+17.5% | -18.66 |
| KEY METRICS | ||||||||
| OPM % | -31.59%+14.14pp | -45.73%+7.92pp | -53.65%+6.88pp | -60.53%+3.35pp | -63.88%+6.75pp | -70.63%+29.37pp | -100.00% | -100.00% |
| NPM % | -35.31%+19.81pp | -55.12%+22.17pp | -77.29%-23.43pp | -53.86%+21.00pp | -74.86%+8.05pp | -82.91%+17.09pp | -100.00% | -100.00% |
| EPS | -0.25+28.6% | -0.35+23.9% | -0.46-21.1% | -0.38+28.3% | -0.53+14.5% | -0.62-3.3% | -0.60+17.8% | -0.73 |
Corporate Events
Board MeetingRCEL
20266Aug
Board Meeting
Second Quarter 2026 Earnings Conference Call and Webcast to …
SEC Filing ↗ Board MeetingRCEL
20263Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify th…
SEC Filing ↗ Board MeetingRCEL
202620May
Board Meeting
Investor webinar briefing and presentation by CEO Cary Vance…
SEC Filing ↗ Board MeetingRCEL
202630Apr
Board Meeting
Cary Vance appointed President and CEO; Jan Stern Reed appoi…
SEC Filing ↗